Hospira Trading Down 2.3% Following Insider Selling (HSP)
Hospira (NYSE:HSP) traded down 2.3% during trading on Tuesday after an insider sold shares in the company, AR Network reports. The company traded as low as $53.86 and last traded at $54.21, with a volume of 1,024,240 shares changing hands. The stock had previously closed at $55.48.
Specifically, CFO Thomas E. Werner unloaded 10,000 shares of Hospira stock on the open market in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $55.13, for a total transaction of $551,300.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
A number of research firms have recently commented on HSP. Analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Hospira in a research note on Thursday, July 31st. They now have a $55.00 price target on the stock, up previously from $42.00. Separately, analysts at Zacks reiterated an “outperform” rating on shares of Hospira in a research note on Thursday, July 31st. They now have a $67.00 price target on the stock. Finally, analysts at Barclays reiterated an “equal weight” rating on shares of Hospira in a research note on Thursday, July 31st. They now have a $47.00 price target on the stock, up previously from $43.00. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $51.38.
The stock has a 50-day moving average of $52.78 and a 200-day moving average of $47.43. The company has a market cap of $9.120 billion and a P/E ratio of 53.50.
Hospira (NYSE:HSP) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.16. The company had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the previous year, the company posted $0.55 earnings per share. The company’s revenue for the quarter was up 10.7% on a year-over-year basis. On average, analysts predict that Hospira will post $2.43 earnings per share for the current fiscal year.
Hospira, Inc (NYSE:HSP) is a provider of injectable drugs and infusion technologies.
Receive News & Ratings for Hospira Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hospira Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.